French pharma giant Sanofi is collaborating with video consultation business Babylon, to offer an online AI Health Service for those who suffer from digestive health issues.
Sanofi is supporting a three-month pilot access to the service, which provides an online symptom checker from British company Babylon for people concerned about digestive health issues. People can get advice through their smartphones via a video consultation with a doctor or artificial intelligence-enabled chatbot.
Read more Oshi Health Launches First All-in-One Mobile App to Allow IBD Patients Manage Their Conditions
Anyone wanting to access this service should visit Buscopan and Dulcolax websites, Sanofi’s over the counter digestive health products.
“Our app not only helps people recognize whether their symptoms are likely to be treatable, but also helps them look at how their diet, health and mood combined affect their health and what they can do to improve it. With the world facing a vast shortage of medical experts, we need to find ways to get information to the patients who need it and help stop small problems become larger ones,” said Dr Keith Grimes, clinical innovation director at Babylon.
Four years ago, Sanofi launched a similar initiative on the two sites, which reportedly saw about 100,000 visits per month.
The new partnership with Babylon stems from a decision to offer a “more sophisticated service”, a spokesperson told MobiHealthNews.
“We knew people were looking for reliable information around IBS and constipation, so we wanted to provide a value-added tech service that would better help them,” explains Roberto Labella, medical head CHC North Europe at Sanofi.
“The service from Babylon Health simplifies healthcare access and can be synced seamlessly to our existing digital channels, making it a great fit.”
Read more FDA Clears Wearable Device to Treat Irritable Bowel Syndrome
This week, Babylon’s subsidiary in Rwanda, Babyl, signed a 10-year partnership with the government of Rwanda to provide every person over the age of 12 with access to digital health consultations, reports MobiHealthNews.
